Literature DB >> 16426816

The mechanism of nasal tolerance in lupus prone mice is T-cell anergy induced by immature B cells that lack B7 expression.

Henry Yim Wu1, Alon Monsonego, Howard L Weiner.   

Abstract

To determine if B cells of lupus prone NZB mice possess intrinsic defects that directly lead or contribute to T-cell hyper-responsiveness, we injected age-, sex- and MHC II-matched NZB and Balb/c mice with histone peptide H471 representing a dominant Th cell epitope in histone H4 of the nucleosome. We found that B220+ B cells of NZB mice express high levels of surface CD86 following antigen priming. We cocultured CD4+ T and B220+ B cells of naïve or peptide primed NZB and Balb/c mice in the presence of peptide. Antigen presentation by autoimmune B cells of NZB mice induced hyper-responsiveness from normal CD4+ T cells of Balb/c mice. T-cell hyper-responsiveness is a result of CD86 costimulation by B cells of NZB mice. Induction of nasal tolerance to H471 in NZB mice suppressed CD86 surface expression and led to downregulation of T-cell proliferative response and cytokine production. More interestingly, B220+ B cells from nasally tolerized NZB mice induced T-cell anergy to anti-CD3 and anti-CD28 antibody stimulation in vitro. The anergic T cells do not possess suppressive function in coculture with naïve responder T cells nor produce suppressive cytokines interleukin 10 and transforming growth factor-beta in vitro.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16426816     DOI: 10.1016/j.jaut.2005.11.005

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  9 in total

1.  Mucosal anti-CD3 monoclonal antibody attenuates collagen-induced arthritis that is associated with induction of LAP+ regulatory T cells and is enhanced by administration of an emulsome-based Th2-skewing adjuvant.

Authors:  Henry Yim Wu; Ruth Maron; Ann-Marcia Tukpah; Howard L Weiner
Journal:  J Immunol       Date:  2010-08-18       Impact factor: 5.422

2.  Presentation of soluble antigens to CD8+ T cells by CpG oligodeoxynucleotide-primed human naive B cells.

Authors:  Wei Jiang; Michael M Lederman; Clifford V Harding; Scott F Sieg
Journal:  J Immunol       Date:  2011-01-14       Impact factor: 5.422

3.  Anti-nuclear antibody production and autoimmunity in transgenic mice that overexpress the transcription factor Bright.

Authors:  Malini Shankar; Jamee C Nixon; Shannon Maier; Jennifer Workman; A Darise Farris; Carol F Webb
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

Review 4.  Neoplastic "Black Ops": cancer's subversive tactics in overcoming host defenses.

Authors:  Arya Biragyn; Dan L Longo
Journal:  Semin Cancer Biol       Date:  2012-01-12       Impact factor: 15.707

Review 5.  Induction of mucosal tolerance in SLE: a sniff or a sip away from ameliorating lupus?

Authors:  Henry Yim Wu
Journal:  Clin Immunol       Date:  2008-10-19       Impact factor: 3.969

6.  Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+ CD25- LAP+ regulatory T cell and is associated with down-regulation of IL-17+ CD4+ ICOS+ CXCR5+ follicular helper T cells.

Authors:  Henry Yim Wu; Francisco J Quintana; Howard L Weiner
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

Review 7.  Pulmonary eosinophilia.

Authors:  Uriel Katz; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

Review 8.  Cell damage and autoimmunity: a critical appraisal.

Authors:  Ian R Mackay; Natasha V Leskovsek; Noel R Rose
Journal:  J Autoimmun       Date:  2008 Feb-Mar       Impact factor: 7.094

Review 9.  Harnessing Tolerogenic Histone Peptide Epitopes From Nucleosomes for Selective Down-Regulation of Pathogenic Autoimmune Response in Lupus (Past, Present, and Future).

Authors:  Syamal K Datta
Journal:  Front Immunol       Date:  2021-04-14       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.